Missing all the overwhelming amount of science coming out of #KidneyWk?
The #NephJC crew has got you covered
Day 2 edition www.nephjc.com/news/kidneyw... via @nephroseeker.medsky.social & moi
Previous #NephJC discussion of felzartamab in transplant ABMR here www.nephjc.com/news/felzart... from @kajareeg.bsky.social and @madihaaziz.bsky.social
Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study
bit.ly/3ZdrYxb #OpenAccess
#VisualAbstract #CKD
#NephMadness 2025: Minimal Change Disease Region
buff.ly/qk4LG8w
Teams:
- MCD Diagnosis and Pathogenesis
- MCD Relapse
Expert: Susan Samuel
Writers: Mallory Downie & Robert Myette
Execs: Ana Catalina Alvarez-Elรญas & @nephrosparks.bsky.social
Visual abstract
Why should HDF produce better vascular access patency?
Observational study, Japan so zero generalizability - nevertheless is there any plausibility to understand beyond the magic of middle molecules and HDF?
academic.oup.com/ndt/advance-... in @ndt-era.bsky.social
#NephSky
Confession: I LOVE hyponatremia ๐ค
(I know, I know. What can I say, I'm a true internist!)
HypoNa is often feared, maligned, and misunderstood - but I promise it doesn't have to be scary!
Here are my top 10 hyponatremia tips and tricks - a ๐งต
#emimcc
ADPKD: Diagnostic algorithm from @kdigo.org
โ Family History
#Nephpearls #NephSky
๐ kdigo.org/guidelines/a...
Anti-hypertensive agents and their effects on Renin and Aldosterone
#Nephpearls #NephSky
๐ Diuretics and MRAs
โฌ๏ธ Renin โฌ๏ธ Aldo
๐ Beta Blockers
โฌ๏ธ Renin โฌ๏ธ Aldo
๐๐ผ shop.elsevier.com/books/hypert...
Frailty in Kidney Disease: A Comprehensive Review to Advance Its Clinical and Research Applications
https://bit.ly/4a7pAvz (FREE)
Resistant Hypertension in CKD ca. 2011
#Nephpearls #NephSky
๐ pubmed.ncbi.nlm.nih.gov/33558253/